Skip to content
★ Sign in to follow
CH
Total declarations
23
Company
1
▲ Purchases (8 ops.)
€1.4M
▼ Sales (6 ops.)
€1.8M

Latest filing published 12 Apr 2017 for Opus Genetics, Inc., €73k.

Filing timeline

BuySale
Chang Ho Ahn

Insider track record

Disclosed buys
8
Disclosed sells
6
Signal history

Closed purchases

Market purchases
8
Positive at T+90
0%
Median T+90
-37.8%

Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 20 May 2011 · 5652 days ago · €926k
    -67.2%
    Entry US$600.00 · Close at T+365 US$196.80
  • Filed 05 Apr 2011 · 5697 days ago · €276k
    -63.4%
    Entry US$590.40 · Close at T+365 US$216.00
  • Filed 15 Apr 2008 · 6782 days ago · €1,520
    -70.2%
    Entry US$1,080.00 · Close at T+365 US$321.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Chang Ho Ahn: trading record in brief

Chang Ho Ahn appears in our data through filings on Opus Genetics, Inc. shares, published by SEC (Form 4). Between 14 April 2008 and 10 April 2017, the trades on record add up to 23 filings.

Both buying and selling appear: 8 purchases worth €1.4M, against 6 sales worth €1.8M. On balance, insiders were net sellers of €484k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 option exercises. Since January 2017: no purchases and 1 sale on the market.

Half of the purchases are above €4,968 and half below. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -37.8%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 12 April 2017 with an option exercise (€73k) in Opus Genetics, Inc. The latest purchase dates back some time: it was published 5,652 days ago, on 20 May 2011. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Chang Ho Ahn

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total
  • ◇
    DirectorExecutivesOpus Genetics, Inc.
    77,500 USD14SEC
    250,000 shares@ US$0.3130.6% of flowCommon StockSEC:0001140361-17-015713:0
  • ▼
    DirectorExecutivesOpus Genetics, Inc.
    175,375 USD18SEC
    250,000 shares@ US$0.701569.4% of flowCommon StockSEC:0001140361-17-015713:1
  • ◇
    DirectorExecutivesOpus Genetics, Inc.
    64,000 USD0SEC
    80,000 shares@ US$0.80Common StockSEC:0001140361-15-001481:0
  • ▼
    DirectorExecutivesOpus Genetics, Inc.
    72,032 USD0SEC
    80,000 shares@ US$0.9004Common StockSEC:0001140361-15-001481:1
  • ◇
    DirectorExecutivesOpus Genetics, Inc.
    148,970 USD0SEC
    186,212 shares@ US$0.80Common StockSEC:0001140361-15-001481:2
  • ▼
    DirectorExecutivesOpus Genetics, Inc.
    170,477 USD0SEC
    186,212 shares@ US$0.9155Common StockSEC:0001140361-15-001481:3
  • ◇
    DirectorExecutivesOpus Genetics, Inc.
    38,755 USD0SEC
    48,444 shares@ US$0.80Common StockSEC:0001140361-15-001481:4
  • ▼
    DirectorExecutivesOpus Genetics, Inc.
    44,263 USD0SEC
    48,444 shares@ US$0.9137Common StockSEC:0001140361-15-001481:5
  • ●
    DirectorExecutivesOpus Genetics, Inc.
    0SEC
    803,924 shares0Common StockSEC:0001140361-14-046139:0
  • ◇
    DirectorExecutivesOpus Genetics, Inc.
    108,954 USD0SEC
    136,193 shares@ US$0.80Common StockSEC:0001140361-14-025828:0
  • ▼
    DirectorExecutivesOpus Genetics, Inc.
    134,436 USD0SEC
    136,193 shares@ US$0.9871Common StockSEC:0001140361-14-025828:1
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    1M USD0SEC
    1,008,078 shares@ US$1.31Common StockSEC:0001140361-11-029093:0
    Canonical exit: 16 Aug 2011 (T+90)
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    391,432 USD0SEC
    320,846 shares@ US$1.22Common StockSEC:0001140361-11-020856:0
    Canonical exit: 30 Jun 2011 (T+90)
  • ●
    Chairman & CEOExecutivesOpus Genetics, Inc.
    0SEC
    300,000 shares0Common StockSEC:0001140361-10-050293:0
  • ●
    Chairman & CEOExecutivesOpus Genetics, Inc.
    0SEC
    210,000 shares0Common StockSEC:0001140361-10-050293:1
  • ●
    Chairman & CEOExecutivesOpus Genetics, Inc.
    0SEC
    400,000 sharesCommon StockSEC:0001140361-09-010936:0
  • ▼
    Chairman & CEOExecutivesOpus Genetics, Inc.
    2M USD0SEC
    2,600,000 shares@ US$0.68Common StockSEC:0001140361-09-010936:1
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    176,800 USD0SEC
    260,000 shares@ US$0.68Common StockSEC:0001140361-09-010936:2
    Canonical exit: 2 Aug 2009 (T+90)
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    6,125 USD0SEC
    2,500 shares@ US$2.45Common StockSEC:0001140361-08-009589:0
    Canonical exit: 13 Jul 2008 (T+90)
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    4,800 USD0SEC
    2,000 shares@ US$2.40Common StockSEC:0001140361-08-009589:1
    Canonical exit: 13 Jul 2008 (T+90)
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    2,400 USD0SEC
    1,000 shares@ US$2.40Common StockSEC:0001140361-08-009589:2
    Canonical exit: 13 Jul 2008 (T+90)
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    9,560 USD0SEC
    4,000 shares@ US$2.39Common StockSEC:0001140361-08-009589:3
    Canonical exit: 13 Jul 2008 (T+90)
  • ▲
    Chairman & CEOExecutivesOpus Genetics, Inc.
    1,100 USD0SEC
    500 shares@ US$2.20Common StockSEC:0001140361-08-009589:4
    Canonical exit: 13 Jul 2008 (T+90)

23 of 23 declarations